Cerium Pharmaceuticals
- Website
- ceriumpharma.com
- Total Funding
- $12.0M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Cerium Pharmaceuticals is dedicated to creating efficacious therapies for patients with kidney diseases and is currently focused on developing the first approved drug for Primary Membranous Nephropathy (PMN), a very rare kidney disease affecting approximately 75,000 patients in the US with about 3,000 newly diagnosed cases each year. The company also pursues challenging development projects, including medicines for pediatric indications and complex biologic agents, and works to make its medicines available globally through Orphan Drug and Named Patient access programs.
Summary
Cerium Pharmaceuticals is a Biotech company. It has raised $12.0M in total across 1 round.
Funding History
Similar Companies
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/cerium-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/cerium-pharmaceuticals" alt="Cerium Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>